ライフサイエンスコーパス: posttraumatic

1 of ICU admission was found as performant as posttraumatic amnesia (area under the curve, 0.81; diffe

2 at ICU admission (phase 1) and compared with posttraumatic amnesia duration and the initial Glasgow C

3 s of ICU admission could be as performant as posttraumatic amnesia for predicting traumatic brain inj

4 Posttraumatic amnesia is superior to the initial Glasgow

5 ble methods of secondary IOL implantation in posttraumatic and postoperative aphakia.

6 tureless Sharioth technique in patients with posttraumatic and postoperative aphakia.

7 The development of posttraumatic brain edema can limit the oxygen utilizati

8 waking brain, and is slowed in the aging and posttraumatic brain.

9 xiety, panic, phobia, obsession, compulsion, posttraumatic, care management, case management, collabo

10 e of Coping Status-A), posttraumatic stress (Posttraumatic Checklist-Specific Stressor), anxiety (Hos

11 outcome was PTSD severity as measured by the Posttraumatic Diagnostic Scale.

12 ossibly contributes to comorbidities such as posttraumatic epilepsy (PTE).

13 etween resilience, stress vulnerability, and posttraumatic growth.

14 Posttraumatic HS is a major cause of preventable death.

15 -treated TBI mice showed the typical chronic posttraumatic hypertrophic morphology.

16 An important trigger of the posttraumatic immune response is the complement anaphyla

17 %); only 15.6% of these studies showed acute posttraumatic intracranial lesions.

18 with mild traumatic brain injury (mTBI) with posttraumatic migraines (PTMs) and those without PTMs on

19 Adverse posttraumatic neuropsychiatric sequelae (APNS) are commo

20 posure, a substantial subset develop adverse posttraumatic neuropsychiatric sequelae (APNS) such as p

21 wn determinant for subsequent development of posttraumatic OA, which accounts for 12% of all OA.

22 We used a murine model of acute, posttraumatic osteomyelitis to evaluate the virulence of

23 omplex regional pain syndrome (CRPS), a rare posttraumatic pain condition.

24 in complex regional pain syndrome (CRPS), a posttraumatic pain disorder.

25 Posttraumatic patients should be kept under medical obse

26 cumstances, to UBM in detecting preoperative posttraumatic PC rupture.

27 udies that both evaluate a broad spectrum of posttraumatic sequelae (to overcome fragmentation) and a

28 nce strongly affects treatment approaches in posttraumatic spectrum disorders, their etiology remains

29 re also significant differences in scores of posttraumatic stress (AMD, -5.86; 95% CI, -8.53 to -3.19

30 y Adjustment Schedule [WHODAS]), symptoms of posttraumatic stress (measured by the Posttraumatic Stre

31 vised), coping (Measure of Coping Status-A), posttraumatic stress (Posttraumatic Checklist-Specific S

32 gnificant levels of depression, anxiety, and posttraumatic stress among patients and levels of burden

33 ttle is understood about how the symptoms of posttraumatic stress develop over time into the syndrome

34 conferences and showed reduced prevalence of posttraumatic stress disorder (45% vs 69%; p = 0.01), an

35 ence letters may even increase prevalence of posttraumatic stress disorder (52.4% vs 37.1%; p = 0.03)

36 ich remained significant after adjusting for posttraumatic stress disorder (adjusted RR = 1.34, 95% c

37 roup analysis revealed a lower prevalence of posttraumatic stress disorder (odds ratio, 0.23; 95% CI,

38 02), bipolar I (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.1

39 ant-reported MVC characteristics with 8-week posttraumatic stress disorder (PTSD) adjusting for pre-M

40 s the prevalence of anxiety, depression, and posttraumatic stress disorder (PTSD) after injury and th

41 earlier trauma exposure is known to predict posttraumatic stress disorder (PTSD) after subsequent tr

42 f exposure to stressful experiences, such as posttraumatic stress disorder (PTSD) and depression, are

43 ales disproportionately have higher rates of posttraumatic stress disorder (PTSD) and experience grea

44 ibitory avoidance-based "2-hit" rat model of posttraumatic stress disorder (PTSD) and identified pred

45 orders with hyperarousal symptoms, including posttraumatic stress disorder (PTSD) and major depressio

46 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

47 ticipants (N=558) were assessed for probable posttraumatic stress disorder (PTSD) and probable depres

48 associated memories is relevant for treating posttraumatic stress disorder (PTSD) and related syndrom

49 ical systems are altered in association with posttraumatic stress disorder (PTSD) and resilience.

50 ration (FDA) as "breakthrough therapies" for posttraumatic stress disorder (PTSD) and treatment-resis

51 s), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common mental d

52 e biomarkers of the presence and severity of posttraumatic stress disorder (PTSD) are elusive, yet ba

53 Patients with posttraumatic stress disorder (PTSD) are hyperresponsive

54 d was a significant risk for a high level of posttraumatic stress disorder (PTSD) arousal symptoms.

55 We prospectively examined posttraumatic stress disorder (PTSD) as a long-term cons

56 Early life trauma (ELT) exposure and posttraumatic stress disorder (PTSD) both affect neural

57 lex traumatic events are at risk of not only posttraumatic stress disorder (PTSD) but also other ment

58 e resilient to psychiatric disorders such as posttraumatic stress disorder (PTSD) compared with those

59 The risk of posttraumatic stress disorder (PTSD) following trauma is

60 Posttraumatic stress disorder (PTSD) has been associated

61 The limited neurobiological understanding of posttraumatic stress disorder (PTSD) has been partially

62 Posttraumatic stress disorder (PTSD) has increasingly be

63 ncreasing predictability of animal models of posttraumatic stress disorder (PTSD) has required active

64 or (alpha1AR) antagonist prazosin for combat posttraumatic stress disorder (PTSD) in 67 active duty s

65 Posttraumatic stress disorder (PTSD) in adolescents is c

66 lable from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of t

67 the neurobiological mechanisms that predict posttraumatic stress disorder (PTSD) in recent trauma su

68 re to stress is a risk factor for developing posttraumatic stress disorder (PTSD) in response to trau

69 al blood during the onset and development of posttraumatic stress disorder (PTSD) indicate widespread

70 Posttraumatic stress disorder (PTSD) is a common psychia

71 Posttraumatic stress disorder (PTSD) is a common psychia

72 Posttraumatic stress disorder (PTSD) is a common, freque

73 Posttraumatic stress disorder (PTSD) is a debilitating d

74 Posttraumatic stress disorder (PTSD) is a debilitating p

75 Posttraumatic stress disorder (PTSD) is a highly prevale

76 Posttraumatic stress disorder (PTSD) is a prevalent and

77 Posttraumatic stress disorder (PTSD) is a prevalent, ser

78 Posttraumatic stress disorder (PTSD) is a psychiatric il

79 Posttraumatic stress disorder (PTSD) is a stress disorde

80 Posttraumatic stress disorder (PTSD) is both a prevalent

81 econsolidation marker.SIGNIFICANCE STATEMENT Posttraumatic stress disorder (PTSD) is characterized by

82 Posttraumatic stress disorder (PTSD) is considered a dis

83 In the aftermath of a disaster, the risk of posttraumatic stress disorder (PTSD) is high.

84 We therefore postulated that posttraumatic stress disorder (PTSD) may be associated w

85 Posttraumatic stress disorder (PTSD) may contribute to h

86 Posttraumatic stress disorder (PTSD) may develop when me

87 ived from genome-wide association studies of posttraumatic stress disorder (PTSD) may inform risk for

88 interactions between smoking and symptoms of posttraumatic stress disorder (PTSD) on pain intensity,

89 Medication and psychotherapy treatments for posttraumatic stress disorder (PTSD) provide insufficien

90 The neural substrates of pediatric posttraumatic stress disorder (PTSD) remain incompletely

91 Studies of posttraumatic stress disorder (PTSD) report volume abnor

92 nced trauma and associated distress-that is, posttraumatic stress disorder (PTSD) severity-more than

93 Studies on posttraumatic stress disorder (PTSD) showing attentional

94 dicate a prevalence for clinically important posttraumatic stress disorder (PTSD) symptoms of 25%.

95 intensive care unit (ICU) might reduce their posttraumatic stress disorder (PTSD) symptoms.

96 in white matter organization in people with posttraumatic stress disorder (PTSD) using diffusion MRI

97 The prevalence of posttraumatic stress disorder (PTSD) was 31.46% (95% CI

98 s process a potential therapeutic target for posttraumatic stress disorder (PTSD), a mental illness c

99 y of daily living, 20% screened positive for posttraumatic stress disorder (PTSD), all SF-12 physical

100 of NPY with trauma-evoked syndromes such as posttraumatic stress disorder (PTSD), although the exact

101 Hippocampus atrophy is implicated in posttraumatic stress disorder (PTSD), and may partly ref

102 ent among veterans, especially veterans with posttraumatic stress disorder (PTSD), and poses a major

103 sychiatric disorders, such as depression and posttraumatic stress disorder (PTSD), are inadequate.

104 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but a comprehensiv

105 smaller hippocampal and amygdala volumes in posttraumatic stress disorder (PTSD), but findings have

106 psychotherapy is a first-line treatment for posttraumatic stress disorder (PTSD), but its mechanisms

107 posure therapy is an effective treatment for posttraumatic stress disorder (PTSD), but many patients

108 to underlie the pathophysiology of pediatric posttraumatic stress disorder (PTSD), but the few studie

109 al patterns of spontaneous brain activity in posttraumatic stress disorder (PTSD), but the findings a

110 r (GR) sensitivity is present in people with posttraumatic stress disorder (PTSD), but the molecular

111 hippocampal volume is frequently observed in posttraumatic stress disorder (PTSD), but the psychologi

112 n array of pathological conditions including posttraumatic stress disorder (PTSD), characterized by d

113 ism rs9315202 and psychopathology, including posttraumatic stress disorder (PTSD), depression, and al

114 cumented heightened systemic inflammation in posttraumatic stress disorder (PTSD), few studies have a

115 d C-reactive protein, have been described in posttraumatic stress disorder (PTSD), generalized anxiet

116 erapy (CPT), an evidence-based treatment for posttraumatic stress disorder (PTSD), has not been teste

117 stress and stress-related disorders, such as posttraumatic stress disorder (PTSD), is a prominent exa

118 e genetic basis of three disorder categories-posttraumatic stress disorder (PTSD), major depressive d

119 eneralization of fear, a cardinal feature of posttraumatic stress disorder (PTSD), manifests as inapp

120 re-based therapy, an effective treatment for posttraumatic stress disorder (PTSD), relies on extincti

121 In about 30-50% of patients with posttraumatic stress disorder (PTSD), symptoms persist a

122 or stress-related psychopathologies, such as posttraumatic stress disorder (PTSD), that are character

123 factor for cardiovascular disease (CVD), and posttraumatic stress disorder (PTSD), the sentinel stres

124 for developing anxiety disorders, including posttraumatic stress disorder (PTSD), the underlying mec

125 e well-known peripheral immune activation in posttraumatic stress disorder (PTSD), there are no studi

126 Posttraumatic stress disorder (PTSD)-a chronic, debilita

127 tress develop over time into the syndrome of posttraumatic stress disorder (PTSD).

128 y few preventive interventions available for posttraumatic stress disorder (PTSD).

129 insufficient to reduce the burden of chronic posttraumatic stress disorder (PTSD).

130 ences, including their propensity to develop posttraumatic stress disorder (PTSD).

131 is widely accepted as a pathogenic marker of posttraumatic stress disorder (PTSD).

132 g in the formation of indelible memories and posttraumatic stress disorder (PTSD).

133 emory processes, and to risk and symptoms of posttraumatic stress disorder (PTSD).

134 identified a role of leaky neuronal RyR2 in posttraumatic stress disorder (PTSD).

135 tric disorders, and is a defining feature of posttraumatic stress disorder (PTSD).

136 f quetiapine monotherapy in the treatment of posttraumatic stress disorder (PTSD).

137 s modulatory transmitter, is associated with posttraumatic stress disorder (PTSD).

138 nimal model of traumatic memory formation in posttraumatic stress disorder (PTSD).

139 the risk of stress-related disorders such as posttraumatic stress disorder (PTSD).

140 d to trauma and may be at increased risk for posttraumatic stress disorder (PTSD).

141 ity to neuropsychiatric disorders, including posttraumatic stress disorder (PTSD).

142 ith histories of childhood abuse and current posttraumatic stress disorder (PTSD).

143 depressive symptoms, prior head injury, and posttraumatic stress disorder (PTSD).

144 ndividuals either resilient or vulnerable to posttraumatic stress disorder (PTSD).

145 exposure and sertraline for the treatment of posttraumatic stress disorder (PTSD).

146 c nausea and prospective risk for developing posttraumatic stress disorder (PTSD).

147 g fear- and trauma-related disorders such as posttraumatic stress disorder (PTSD).

148 e development of mental disorders, including posttraumatic stress disorder (PTSD).

149 ala reactivity is a vulnerability factor for posttraumatic stress disorder (PTSD); however, our under

150 hose who screened positive for depression or posttraumatic stress disorder after return from deployme

151 rove health-related quality of life, but not posttraumatic stress disorder among ICU survivors and ma

152 r among ICU survivors and may result in less posttraumatic stress disorder among relatives of ICU pat

153 New possibilities for treating posttraumatic stress disorder and anxiety disorders invo

154 pite significant overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the

155 es an updated review of sleep disturbance in posttraumatic stress disorder and anxiety-related disord

156 elin signaling may enhance susceptibility to posttraumatic stress disorder and comorbid conditions su

157 thasone compared with placebo on symptoms of posttraumatic stress disorder and depression and health-

158 nts, beneficial effects on the occurrence of posttraumatic stress disorder and depression may be pres

159 Posttraumatic stress disorder and depression were presen

160 nea and insomnia), mental health status (eg, posttraumatic stress disorder and depression), nonocular

161 e blast TBI was also observed on measures of posttraumatic stress disorder and depression.

162 ively or negatively affect the prevalence of posttraumatic stress disorder and depression.

163 stoperative admission to the ICU may lead to posttraumatic stress disorder and depression.

164 by deficient neurosteroidogenesis, including posttraumatic stress disorder and major depressive disor

165 es in connectivity in patients with comorbid posttraumatic stress disorder and MDD.

166 responses and have been have been linked to posttraumatic stress disorder and other mental health af

167 le target in developing novel treatments for posttraumatic stress disorder and related disorders.

168 s potential therapeutic effects for treating posttraumatic stress disorder are related to altering em

169 -year anxiety disorders, mood disorders, and posttraumatic stress disorder by sexual identity (hetero

170 ew Version (PSS-I) and the stressor-specific Posttraumatic Stress Disorder Checklist (PCL-S); seconda

171 oms of posttraumatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personal

172 outcomes were posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist for DSM-5), func

173 onnaire) and post-traumatic stress symptoms (Posttraumatic Stress Disorder Checklist).

174 s 6 months after patient discharge using the Posttraumatic Stress Disorder Checklist-Civilian Version

175 y was assessed at hospital discharge via the Posttraumatic Stress Disorder Checklist-Specific scale;

176 ck women experienced higher risk of lifetime posttraumatic stress disorder compared with white women.

177 ses including mild traumatic brain injury or posttraumatic stress disorder display alterations on ASL

178 Secondary outcomes included posttraumatic stress disorder experienced by the family

179 conversely, to the potential development of posttraumatic stress disorder following trauma.

180 The Psychiatric Genomics Consortium-Posttraumatic Stress Disorder group (PGC-PTSD) combined

181 co-occurring psychiatric conditions and with posttraumatic stress disorder having the largest impact.

182 polymorphism, rs4523957, is associated with posttraumatic stress disorder in humans, consistent with

183 that PACAP dysregulation is associated with posttraumatic stress disorder in humans.

184 health, increasing depression, anxiety, and posttraumatic stress disorder in these same villages.

185 Posttraumatic stress disorder is often comorbid with MDD

186 nisms of severe sepsis in the development of posttraumatic stress disorder need further examination.

187 There has been relatively little study of posttraumatic stress disorder or obsessive-compulsive di

188 ntify anxiety, stress, caregiver burden, and posttraumatic stress disorder outcomes in informal careg

189 of threat.SIGNIFICANCE STATEMENT Anxiety and posttraumatic stress disorder patients generalize fear t

190 of targeting the renin-angiotensin system in posttraumatic stress disorder remain unknown.

191 (OR, 1.15; 95% CI, 1.02-1.30; P = .02), and posttraumatic stress disorder score (OR, 1.04; 95% CI, 1

192 fied between overall DE symptom severity and posttraumatic stress disorder scores and tear breakup ti

193 uman postmortem datasets from depression and posttraumatic stress disorder studies have identified ma

194 Posttraumatic stress disorder symptomatology is common a

195 An in-person posttraumatic stress disorder symptomatology was assesse

196 rlson index of zero) had higher frequency of posttraumatic stress disorder symptoms (adjusted odds ra

197 rrest and subsequent hospitalization-induced posttraumatic stress disorder symptoms (cardiac arrest-i

198 ationship to whole-brain cortical thickness, posttraumatic stress disorder symptoms (PTSD) and depres

199 The prevalence of long-term posttraumatic stress disorder symptoms among family memb

200 patient- and family-member risk factors for posttraumatic stress disorder symptoms among family memb

201 e individuals, increased lifetime stress and posttraumatic stress disorder symptoms explained the maj

202 Family member risk factors for posttraumatic stress disorder symptoms included preexist

203 studies reported significant improvement in posttraumatic stress disorder symptoms of relatives of I

204 Posttraumatic stress disorder symptoms were higher in th

205 Posttraumatic stress disorder symptoms were present in 3

206 found no significant reduction in patients' posttraumatic stress disorder symptoms with ICU diaries

207 The primary outcome was posttraumatic stress disorder symptoms, and secondary ou

208 significant general anxiety, depression, or posttraumatic stress disorder symptoms, and these sympto

209 y healthy patients are at increased risk for posttraumatic stress disorder symptoms.

210 r depression symptoms and may have increased posttraumatic stress disorder symptoms.

211 ess severity were not associated with family posttraumatic stress disorder symptoms.

212 lthough symptoms of anxiety, depression, and posttraumatic stress disorder were found to be common 1

213 ental Disorders (version IV) Criterion A for posttraumatic stress disorder were interviewed.

214 %, 42%, and 24% for depression, anxiety, and posttraumatic stress disorder) at 6 and 12 months.

215 , bipolar disorder, depression, anxiety, and posttraumatic stress disorder) with major CVD outcomes (

216 , 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress disorder, 9.8%; alcohol dependence,

217 specific psychiatric disorders (depression, posttraumatic stress disorder, addiction, social anxiety

218 s (i.e., sex of the exposed parent, parental posttraumatic stress disorder, age at Holocaust exposure

219 Posttraumatic stress disorder, an area of large unmet me

220 pulsive disorder, major depressive disorder, posttraumatic stress disorder, and addiction.

221 target for treatment of depression, anxiety, posttraumatic stress disorder, and also against age-rela

222 ast 6-month generalized anxiety disorder and posttraumatic stress disorder, and past 12-month alcohol

223 tions, such as generalized anxiety disorder, posttraumatic stress disorder, and social anxiety disord

224 d chemotherapy-related cognitive impairment, posttraumatic stress disorder, and traumatic brain injur

225 l comorbid psychiatric conditions, including posttraumatic stress disorder, anxiety disorders, obsess

226 Mental disorders (any disorder, mood, posttraumatic stress disorder, anxiety, alcohol use diso

227 ive disorders (mean scores >35), followed by posttraumatic stress disorder, borderline personality di

228 of traumatic events is a hallmark symptom of posttraumatic stress disorder, characterized by rich and

229 Symptoms of posttraumatic stress disorder, depression, and health-re

230 antify the impact of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and

231 ty disorders, obsessive-compulsive disorder, posttraumatic stress disorder, depressive disorders, bip

232 Intelligence was not associated with posttraumatic stress disorder, eating disorders, and anx

233 rders, such as major depressive disorder and posttraumatic stress disorder, exact enormous socioecono

234 entia among men with stress disorders except posttraumatic stress disorder, for which women had a hig

235 he primary symptoms linked to deployment are posttraumatic stress disorder, mood disorders, GI proble

236 y a role in the formation and persistence of posttraumatic stress disorder, of which sleep impairment

237 nalyses used a priori seeds relevant to TMS, posttraumatic stress disorder, or MDD (subgenual anterio

238 In psychiatric disorders such as posttraumatic stress disorder, PFC hyperactivity is asso

239 (mood, anxiety, substance use, personality, posttraumatic stress disorder, schizophrenia, and psycho

240 Five anxiety disorders were included: posttraumatic stress disorder, social anxiety disorder,

241 suicidal plan, bipolar disorder, psychosis, posttraumatic stress disorder, substance dependence, cur

242 understand black women's heightened risk for posttraumatic stress disorder.

243 cessing (EMDR) is an effective treatment for posttraumatic stress disorder.

244 ess-related disorders, including anxiety and posttraumatic stress disorder.

245 oraphobia, obsessive-compulsive disorder, or posttraumatic stress disorder.

246 ical populations, with a particular focus on posttraumatic stress disorder.

247 ive disorders including major depression and posttraumatic stress disorder.

248 hods for primary prevention and treatment of posttraumatic stress disorder.

249 onditions such as autism, schizophrenia, and posttraumatic stress disorder.

250 disrupted in psychiatric conditions such as posttraumatic stress disorder.

251 depressant for major depressive disorder and posttraumatic stress disorder.

252 qual to 35, indicating a high probability of posttraumatic stress disorder.

253 ium and symptoms of anxiety, depression, and posttraumatic stress disorder.

254 rium and symptoms of anxiety, depression, or posttraumatic stress disorder.

255 vant to spatial memory deficits described in posttraumatic stress disorder.

256 of Event Scale 15 item measuring symptoms of posttraumatic stress disorder.

257 illnesses like major depressive disorder and posttraumatic stress disorder.

258 spatial memory dysfunction in, for example, posttraumatic stress disorder.

259 ychiatric conditions, such as depression and posttraumatic stress disorder.

260 tion regulation in insomnia, depression, and posttraumatic stress disorder.

261 , including generalized anxiety disorder and posttraumatic stress disorder.

262 eveloping this drug class as a treatment for posttraumatic stress disorder.

263 illnesses, such as depression, anxiety, and posttraumatic stress disorder.

264 per 100 for hypertension to 0.6 per 100 for posttraumatic stress disorder.

265 e therapy in the clinic for the treatment of posttraumatic stress disorder.

266 ors report long-term psychologic symptoms of posttraumatic stress disorder.

267 on on emotional behavior in a mouse model of posttraumatic stress disorder.

268 nd 78 patients (13.8%) who received placebo (posttraumatic stress disorder: odds ratio, 0.82; 95% CI,

269 yment (depression: OR, 1.4; 95% CI, 1.1-1.9; posttraumatic stress disorder: OR, 2.4; 95% CI, 2.1-2.8)

270 in-angiotensin system has been implicated in posttraumatic stress disorder; however, the mechanisms r

271 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders and to evaluate whether a

272 ld higher prevalence of major depressive and posttraumatic stress disorders in women compared with me

273 erapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders is unclear.

274 may have high levels of anxiety, depression, posttraumatic stress disorders, and/or complicated grief

275 Other conditions represented were psychotic, posttraumatic stress or anxiety, somatoform, neurocognit

276 equal to 14 (interquartile range, 5-20) and Posttraumatic Stress Scale equal to 22 (interquartile ra

277 tal Anxiety and Depression Scale; p = 0.010, Posttraumatic Stress Scale), resilience (p = 0.012, Hosp

278 he Hospital Anxiety and Depression Scale and Posttraumatic Stress Scale.

279 ange of postdisaster trajectories of chronic posttraumatic stress symptom (PTSS) and depression sympt

280 t in PTSD vs. controls, were associated with posttraumatic stress symptom (PTSS) severity, or were af

281 l coupling may also be related to subsequent posttraumatic stress symptom severity.

282 screened positive for cardiac arrest-induced posttraumatic stress symptomatology at discharge (median

283 Cardiac arrest-induced posttraumatic stress symptomatology was associated with

284 r cardiac arrest, and cardiac arrest-induced posttraumatic stress symptomatology was associated with

285 ss disorder symptoms (cardiac arrest-induced posttraumatic stress symptomatology) at hospital dischar

286 Secondary outcomes were posttraumatic stress symptoms (Posttraumatic Stress Diso

287 d social support, cognitive functioning, and posttraumatic stress symptoms were also assessed using s

288 Cognitive functioning and posttraumatic stress symptoms were both significantly as

289 hological distress (anxiety, depression, and posttraumatic stress).

290 Rates of clinically significant posttraumatic stress, anxiety, and depressive symptoms w

291 gnificant levels of anxiety, depression, and posttraumatic stress, as well as cognitive function and

292 tic neuropsychiatric sequelae (APNS) such as posttraumatic stress, major depression, and regional or

293 e APNS, as traditionally classified, include posttraumatic stress, postconcussion syndrome, depressio

294 cantly different regarding the prevalence of posttraumatic stress-related symptoms (52.3 vs 50%, resp

295 tionnaire and the Impact of Event Scale (for posttraumatic stress-related symptoms) 3 months later.

296 sion subscale scores but not with changes in posttraumatic stress-related symptoms.

297 ent negative life events, and depressive and posttraumatic-stress-disorder symptom scores with placen

298 Primary measures were scores on the Posttraumatic Symptom Scale-Interview Version (PSS-I) an

299 eficits belong to the most prevalent chronic posttraumatic symptoms, most likely due to diffuse axona

300 egulated systems known to be associated with posttraumatic symptoms.